Cystadane
What Cystadane is used for
Adjunctive treatment of homocystinuria, involving deficiencies or defects in: cystathionine beta-synthase (CBS); 5,10-methylene-tetrahydrofolate reductase (MTHFR); cobalamin cofactor metabolism (cbl). Cystadane should be used as supplement to other therapies such as vitamin B6 (pyridoxine), vitamin B12 (cobalamin), folate and a specific diet.
Approved use, as published by the European Medicines Agency.
Key facts
- Brand
- Cystadane
- Active substance
- betaine anhydrous
- Disease area
- Homocystinuria
- Medicine group
- Other alimentary tract and metabolism products
- ATC code
- A16AA06
- Marketing authorisation holder
- Recordati Rare Diseases
- Authorised in the EU since
- 2007
Official information
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Cystadane used for?
Adjunctive treatment of homocystinuria, involving deficiencies or defects in: cystathionine beta-synthase (CBS); 5,10-methylene-tetrahydrofolate reductase (MTHFR); cobalamin cofactor metabolism (cbl). Cystadane should be used as supplement to other therapies such as vitamin B6 (pyridoxine), vitamin B12 (cobalamin), folate and a specific diet.
What is the active substance in Cystadane?
Cystadane contains betaine anhydrous.
Who makes Cystadane?
The EU marketing authorisation holder is Recordati Rare Diseases.
Source: European Medicines Agency medicines data (ema.europa.eu), reproduced with acknowledgement of the source. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, EU